Arkolith/Insider Trading/CLSD/Form 4

Lasezkay George M

CEO, DirectorClearside Biomedical, Inc. (CLSD) · full profile →Form 4 · filed Sep 23, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$23K
Net Open-Market Flow
-$23K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 21, 2021Sell(S)4K$6.46$23K423K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-057459) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML